Phencyclidine Antibody (BDI970): sc-57969

Phencyclidine Antibody (BDI970) is a mouse monoclonal IgG1 antibody that detects Phencyclidine in non-species reactive samples through enzyme-linked immunosorbent assay (ELISA). Phencyclidine, also known as PCP, is a dissociative drug that was originally developed as an anesthetic agent but is now recognized for its hallucinogenic and neurotoxic effects. This compound primarily acts as an agonist at the N-methyl-D-aspartate (NMDA) receptor, leading to prolonged neuronal depolarization and effectively inhibiting NMDA receptor activity. The significance of this interaction lies in its potential to induce a range of neurological effects, including cognitive impairment and altered sensory perception, which can have profound implications for both recreational users and individuals exposed to the drug in clinical settings. Additionally, Phencyclidine is classified as a Schedule II controlled substance due to its potential for abuse and the risk of causing brain damage, specifically Olney′s lesions. With a molecular weight of 243.387 g/mol, Phencyclidine′s psychoactive effects may last for only a few hours; however, elimination from the body can take weeks, underscoring the importance of understanding its pharmacokinetics and long-term impact on health. Anti-Phencyclidine antibody (BDI970) is an essential tool for researchers studying the effects and mechanisms of this complex compound.